在慢性乙型肝炎患者中，肝星状细胞大量活化增生。
The clinical study elucidated that the HSC was activated and proliferated in patients with chronic hepatitis B.
目的探讨纽曼系统模式护理程序在慢性乙型肝炎患者护理中的作用。
Objective To explore the effect of Neuman systems model nursing process in nursing of patients with chronic hepatitis B.
目的：探讨趋化性细胞因子受体CXCR3在慢性乙型肝炎症发生机制中的作用。
AIM: to explore the role of chemokine receptor CXCR3 in pathogenesis of chronic hepatitis B.
目的 ：探讨趋化性细胞因子受体CXCR3在慢性乙型肝炎症发生机制中的作用。
Objective:To assess the important role of chemokine receptor CCR4 and CXCR3 in patients with atopic dermatitis.
目的探讨细胞免疫在慢性乙型肝炎病毒（HBV）感染中的作用和干扰素治疗对细胞免疫的影响。
Objective To explore the action of cellular immunity in chronic HBV infection and the effect of interferon.
结论肝细胞HSP70的异常表达在慢性乙型肝炎免疫保护中起重要作用，可作为肝组织损伤的一种标志。
Conclusion Expression of HSP70 in hepatocytes may play an important role in liver immunological protection, and may be a marker of liver tissue injury in chronic hepatitis b.
目的：面对全球的疾病负担，研究拉米夫定和类似的单一疗法作为一种治疗策略在慢性乙型肝炎治疗中的可行性。
Methods: we have reviewed the role of lamivudine monotherapy in the treatment of chronic HBV in a single tertiary referral liver centre over a 9-year period.
例如，在慢性乙型肝炎病毒和艾滋病病毒治疗期间发生艾滋病毒感染和耐药变异时CXCR 4向性病毒的出现可作为这种持续演变的表型证据。
Phenotypic evidence of this continuing evolution is seen, for example, in the emergence of CXCR4 tropic viruses during HIV infection and drug-resistant variants during chronic HBV and HIV therapy.
这些基本而又不同的治疗选择每一种均具有一定的优势和局限性在抗慢性乙型肝炎病毒中具有一定定位。
Each of these fundamentally different approaches has advantages and limitations and both have a place in the therapeutic armamentarium against chronic hepatitis b.
在我国，乙型肝炎病毒(HBV)相关的急慢性终末期肝病逐渐成为肝移植的主要适应症。
In our country, acute or chronic HBV-related end-stage liver diseases serve as the main indication of the liver transplantation, which is likely to bring about the reinfection of HBV post-LT.
目的：研究促肝细胞生长素注射液（威佳）在治疗慢性乙型肝炎（CHB）高胆红素血症中的作用。
Objective: To investigate the effect of hepatocyte growth-promoting factors injection (Weijia) in the treatment of hyperbilirubinemia in patients with chronic hepatitis B (CHB) .
目的研究乙型肝炎（乙肝）病毒核心基因内缺失突变株（ C I D）在慢性乙肝及肝癌患者中存在的状态及意义。
Objective To study the status and significance of hepatitis B virus core internal deletion (CID) mutants in chronic hepatitis B and hepatocellular carcinoma patients.
在非洲和亚洲的农村地区，这种疫苗是无法获得的，经济上也负担不起，这就是为什么慢性乙型肝炎患病率仍然居高不下，预计这种情况将保持不变。
This vaccine is unavailable and out-of-reach financially in rural Africa and Asia, which is why chronic hepatitis B rates remain stubbornly high and are projected to remain unchanged.
中医药在治疗慢性病毒性乙型肝炎方面具有“简、便、廉、验”的优势，是我国治疗慢性病毒性乙型肝炎的特色与优势。
Chinese medicine in the treatment of chronic hepatitis B has "Jane, we, inexpensive and postmortem" advantage is the treatment of chronic hepatitis B in China's characteristics and advantages.
目的研究激活诱导细胞死亡（AICD）现象在乙型肝炎慢性化和重型化机制中的意义。
ObjectiveTo study the significance of AICD(activation-induced cell death) in the pathogenesis of chronic hepatitis B and chronic severe hepatitis B.
中医药在防治慢性乙型肝炎合并嗜酒方面具有潜在的优势和鲜明的特点。
The Chinese medicine has latent superiority and bright characteristic in the prevention and treatment of chronic hepatitis B combined with Alcoholomania.
在全球的所有慢性乙型肝炎病例中，亚裔人士占75%。
Worldwide, 75 percent of all chronic hepatitis B cases are persons of Asian origin.
在全球的所有慢性乙型肝炎病例中，亚裔人士占75%。
Worldwide, 75 percent of all chronic hepatitis B cases are persons of Asian origin.
应用推荐